Literature DB >> 9033475

Nitric oxide synthase inhibition in migraine.

L H Lassen, M Ashina, I Christiansen, V Ulrich, J Olesen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9033475     DOI： 10.1016/s0140-6736(97)80021-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  39 in total

Review 1.  Chemical mediators of migraine: preclinical and clinical observations.

Authors:  Saurabh Gupta; Stephanie J Nahas; B Lee Peterlin
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

2.  Headache.

Authors:  Peter J Goadsby
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

Review 3.  Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.

Authors:  Peter J Goadsby
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Localization of nitric oxide synthase in rat trigeminal primary afferent neurons using NADPH-diaphorase histochemistry.

Authors:  I I Stoyanova; N E Lazarov
Journal:  J Mol Histol       Date:  2005-03       Impact factor: 2.611

5.  Presence of Headache and Migraine in Asthma Patients.

Authors:  Muzaffer Onur Turan; Çiğdem Çelik Susuz; Pakize Ayşe Turan
Journal:  Turk Thorac J       Date:  2017-04-01

Review 6.  Nitric oxide signalling in the brain and its control of bodily functions.

Authors:  Konstantina Chachlaki; Vincent Prevot
Journal:  Br J Pharmacol       Date:  2019-09-08       Impact factor: 8.739

Review 7.  Nitric oxide-related drug targets in headache.

Authors:  Jes Olesen
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

Review 8.  Emerging targets in migraine.

Authors:  Jan Hoffmann; Peter J Goadsby
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

Review 9.  Migraine is a neuronal disease.

Authors:  J Tajti; A Párdutz; E Vámos; B Tuka; A Kuris; Zs Bohár; A Fejes; J Toldi; L Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2010-12-15       Impact factor: 3.575

Review 10.  Migraine pathogenesis and state of pharmacological treatment options.

Authors:  Till Sprenger; Peter J Goadsby
Journal:  BMC Med       Date:  2009-11-16       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.